Market revenue in 2023 | USD 15.5 million |
Market revenue in 2030 | USD 29.5 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.42% in 2023. Horizon Databook has segmented the India clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
India has rapidly become one of the most preferred sites for clinical trials due to the presence of a large, diversified patient pool, a fast-developing healthcare sector, highly educated physicians, and cost competitiveness.
Furthermore, investment from overseas firms in research is expected to support market growth over the forecast period. The outsourcing of clinical trials has significantly increased in the country owing to cost-effectiveness, a large patient pool, fast enrollment, and a developing hospital network.
India's global clinical trial activity has increased compared to the 10-year average. For instance, as per estimates from Global Data, the global clinical trial activity in India accounted for 6.2% in 2021, compared to the 10-year average of 6.4%.
Horizon Databook provides a detailed overview of country-level data and insights on the India clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into India clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account